Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Imazio

Showing results (211-220 of 483) with videos related to

Pageof 49
Sort By:
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 5, 2021
Adverse events of colchicine for cardiovascular diseases: a comprehensive meta-analysis of 14 188 patients from 21 randomized controlled trialsAlessandro Andreis, Massimo Imazio, Stefano Avondo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 4, 2010
Triage and management of pericardial effusionMassimo Imazio, Bongani M Mayosi, Antonio Brucato, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 13, 2013
Controversies in the prophylaxis and treatment of postsurgical pericardial syndromes: a critical review with a special emphasis on paediatric ageMassimiliano Cantinotti, Isabella Spadoni, Nadia Assanta, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 20, 2015
Anakinra: an emerging option for refractory idiopathic recurrent pericarditis: a systematic review of published evidenceGeorge Lazaros, Massimo Imazio, Antonio Brucato, et al.
Annals of the Rheumatic Diseases|August 29, 2020
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre <i>et al</i>Silvia Piantoni, Enrico Colombo, Roberto Furloni, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 9, 2016
Multimodality imaging of pericardial diseasesMassimo Imazio, Patrizia Pedrotti, Giuseppina Quattrocchi, et al.
The American Journal of Cardiology|September 11, 2007
Prognosis of idiopathic recurrent pericarditis as determined from previously published reportsMassimo Imazio, Antonio Brucato, Yehuda Adler, et al.
Heart Rhythm O2|January 6, 2022
Oral procainamide as pharmacological treatment of recurrent and refractory ventricular tachyarrhythmias: A single-center experienceMauro Toniolo, Daniele Muser, Giulia Grilli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2021
COVID-19 Disease in Patients With Recurrent Pericarditis During Treatment With Anakinra: Comment on the Article by Navarro-Millán et alEnrica Negro, Lucia Trotta, Massimo Pancrazi, et al.
Internal and Emergency Medicine|June 27, 2019
Prevalence and prognostic impact of left ventricular non-compaction in patients with thalassemiaRodolfo Bonamini, Massimo Imazio, Riccardo Faletti, et al.
Pageof 49

Showing results (211-220 of 483) with videos related to

Sort By:
Pageof 49
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 5, 2021
Adverse events of colchicine for cardiovascular diseases: a comprehensive meta-analysis of 14 188 patients from 21 randomized controlled trialsAlessandro Andreis, Massimo Imazio, Stefano Avondo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 4, 2010
Triage and management of pericardial effusionMassimo Imazio, Bongani M Mayosi, Antonio Brucato, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 13, 2013
Controversies in the prophylaxis and treatment of postsurgical pericardial syndromes: a critical review with a special emphasis on paediatric ageMassimiliano Cantinotti, Isabella Spadoni, Nadia Assanta, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 20, 2015
Anakinra: an emerging option for refractory idiopathic recurrent pericarditis: a systematic review of published evidenceGeorge Lazaros, Massimo Imazio, Antonio Brucato, et al.
Annals of the Rheumatic Diseases|August 29, 2020
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre <i>et al</i>Silvia Piantoni, Enrico Colombo, Roberto Furloni, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 9, 2016
Multimodality imaging of pericardial diseasesMassimo Imazio, Patrizia Pedrotti, Giuseppina Quattrocchi, et al.
The American Journal of Cardiology|September 11, 2007
Prognosis of idiopathic recurrent pericarditis as determined from previously published reportsMassimo Imazio, Antonio Brucato, Yehuda Adler, et al.
Heart Rhythm O2|January 6, 2022
Oral procainamide as pharmacological treatment of recurrent and refractory ventricular tachyarrhythmias: A single-center experienceMauro Toniolo, Daniele Muser, Giulia Grilli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2021
COVID-19 Disease in Patients With Recurrent Pericarditis During Treatment With Anakinra: Comment on the Article by Navarro-Millán et alEnrica Negro, Lucia Trotta, Massimo Pancrazi, et al.
Internal and Emergency Medicine|June 27, 2019
Prevalence and prognostic impact of left ventricular non-compaction in patients with thalassemiaRodolfo Bonamini, Massimo Imazio, Riccardo Faletti, et al.
Pageof 49